Cristiane Neves Alessi Pissulin1, Ana Angélica Henrique Fernandes2, Alejandro Manuel Sanchez Orellana3, Renata Calciolari Rossi E Silva4, Selma Maria Michelin Matheus5. 1. Department of Anatomy, Universidade do Oeste Paulista (UNOESTE), Presidente Prudente, SP, Brazil; General Bases of Surgery, Botucatu Medical School, Unesp, Botucatu, SP, Brazil. Electronic address: crispissulin@gmail.com. 2. Department of Chemistry and Biochemistry, Institute of Bioscience, Unesp, Botucatu, SP, Brazil. Electronic address: angelica@ibb.unesp.br. 3. Unesp, Institute of Bioscience, Botucatu, SP, Brazil. Electronic address: alesanc96@outlook.com. 4. Department of Pathology, Universidade do Oeste Paulista (UNOESTE), Presidente Prudente, SP, Brazil. Electronic address: renata@unoeste.br. 5. Department of Anatomy, Institute of Bioscience, General Bases of Surgery, Botucatu Medical School, Unesp, Botucatu, SP, Brazil. Electronic address: micmath@ibb.unesp.br.
Abstract
BACKGROUND: Because of its long-lasting analgesic action, bupivacaine is an anesthetic used for peripheral nerve block and relief of postoperative pain. Muscle degeneration and neurotoxicity are its main limitations. There is strong evidence that low-level laser therapy (LLLT) assists in muscle and nerve repair. The authors evaluated the effects of a Gallium Arsenide laser (GaAs), on the regeneration of muscle fibers of the sternomastoid muscle and accessory nerve after injection of bupivacaine. METHODS: In total, 30 Wistar adult rats were divided into 2 groups: control group (C: n=15) and laser group (L: n=15). The groups were subdivided by antimere, with 0.5% bupivacaine injected on the right and 0.9% sodium chloride on the left. LLLT (GaAs 904nm, 0,05W, 2.8J per point) was administered for 5 consecutive days, starting 24h after injection of the solutions. Seven days after the trial period, blood samples were collected for determination of creatine kinase (CK). The sternomastoid nerve was removed for morphological and morphometric analyses; the surface portion of the sternomastoid muscle was used for histopathological and ultrastructural analyses. Muscle CK and TNFα protein levels were measured. RESULTS: The anesthetic promoted myonecrosis and increased muscle CK without neurotoxic effects. The LLLT reduced myonecrosis, characterized by a decrease in muscle CK levels, inflammation, necrosis, and atrophy, as well as the number of central nuclei in the muscle fibers and the percentage of collagen. TNFα values remained constant. CONCLUSIONS: LLLT, at the dose used, reduced fibrosis and myonecrosis in the sternomastoid muscle triggered by bupivacaine, accelerating the muscle regeneration process.
BACKGROUND: Because of its long-lasting analgesic action, bupivacaine is an anesthetic used for peripheral nerve block and relief of postoperative pain. Muscle degeneration and neurotoxicity are its main limitations. There is strong evidence that low-level laser therapy (LLLT) assists in muscle and nerve repair. The authors evaluated the effects of a Gallium Arsenide laser (GaAs), on the regeneration of muscle fibers of the sternomastoid muscle and accessory nerve after injection of bupivacaine. METHODS: In total, 30 Wistar adult rats were divided into 2 groups: control group (C: n=15) and laser group (L: n=15). The groups were subdivided by antimere, with 0.5% bupivacaine injected on the right and 0.9% sodium chloride on the left. LLLT (GaAs 904nm, 0,05W, 2.8J per point) was administered for 5 consecutive days, starting 24h after injection of the solutions. Seven days after the trial period, blood samples were collected for determination of creatine kinase (CK). The sternomastoid nerve was removed for morphological and morphometric analyses; the surface portion of the sternomastoid muscle was used for histopathological and ultrastructural analyses. Muscle CK and TNFα protein levels were measured. RESULTS: The anesthetic promoted myonecrosis and increased muscle CK without neurotoxic effects. The LLLT reduced myonecrosis, characterized by a decrease in muscle CK levels, inflammation, necrosis, and atrophy, as well as the number of central nuclei in the muscle fibers and the percentage of collagen. TNFα values remained constant. CONCLUSIONS: LLLT, at the dose used, reduced fibrosis and myonecrosis in the sternomastoid muscle triggered by bupivacaine, accelerating the muscle regeneration process.
Authors: Donna R Webb; Sheba R Churchill; Georgette D Hill; Christopher A McGee; Min Shi; Angela P King-Herbert; Terry L Blankenship-Paris Journal: Comp Med Date: 2021-04-16 Impact factor: 0.982
Authors: Caroline Pereira Santos; Andreo Fernando Aguiar; Ines Cristina Giometti; Thaoan Bruno Mariano; Carlos Eduardo Assumpção de Freitas; Gisele Alborghetti Nai; Selma Zambelli de Freitas; Maeli Dal Pai-Silva; Francis Lopes Pacagnelli Journal: Lasers Med Sci Date: 2018-01-15 Impact factor: 3.161
Authors: Juan Liu; Dominik Saul; Kai Oliver Böker; Jennifer Ernst; Wolfgang Lehman; Arndt F Schilling Journal: Biomed Res Int Date: 2018-04-16 Impact factor: 3.411